No, Fibracol and Promogran Are Not the Same Product
Fibracol and Promogran are distinct wound dressings with different compositions and mechanisms of action. Fibracol is a collagen-alginate dressing, while Promogran is a collagen-oxidized regenerated cellulose (ORC) dressing, with some formulations containing silver (Promogran Prisma).
Key Compositional Differences
Fibracol
- Composition: Collagen combined with alginate (a seaweed-derived polysaccharide)
- Primary mechanism: Provides structural support for wound healing while alginate component manages exudate through absorption and gel formation 1
- Function: The alginate component creates a moist wound environment and absorbs wound fluid
Promogran
- Composition: Collagen combined with oxidized regenerated cellulose (ORC), with or without silver
- Primary mechanism: Binds and inactivates matrix metalloproteinases (MMPs) in the chronic wound environment, protecting growth factors 2, 3
- Function: Targets biochemical imbalances in chronic wounds by modulating the wound microenvironment at a molecular level
Clinical Evidence and Effectiveness
Current guidelines strongly recommend against using either product for diabetic foot ulcers. The 2024 IWGDF guidelines provide a strong recommendation (with low certainty evidence) to not use collagen or alginate dressings for wound healing in diabetes-related foot ulcers 4.
Evidence for Fibracol
- One study showed 80.6% mean wound area reduction versus 61.1% with gauze, though this difference was not statistically significant 1
- The study demonstrated safety comparable to standard gauze dressings
Evidence for Promogran
- A multicenter trial of 276 patients showed 37% complete healing with Promogran versus 28.3% with gauze (not statistically significant, p=0.12) 2
- Showed marginal benefit (borderline significance, p=0.056) only in ulcers less than 6 months duration
- No benefit demonstrated for chronic ulcers ≥6 months duration
Important Clinical Caveats
Both products fall under the same guideline recommendation against routine use, but for different reasons:
Collagen-alginate products (like Fibracol): The 2024 guidelines reviewed 12 RCTs of collagen or alginate dressings, with 9 of 12 showing no difference in wound healing 4
Collagen-ORC products (like Promogran): While the mechanism of MMP modulation is theoretically sound, clinical evidence has not demonstrated consistent superiority over standard care 2
When Either Might Be Considered
Despite guideline recommendations against routine use, these products may have limited roles:
Complex wounds with exposed structures: Promogran Prisma combined with negative pressure wound therapy showed 89% success in covering exposed tendons/bone in lower extremity wounds 5
Non-diabetic wounds: The guideline restrictions specifically address diabetic foot ulcers; evidence for other wound types is separate
Resource-limited settings: Where standard sharp debridement and basic moisture-retentive dressings are available, neither product adds proven benefit
Bottom Line for Clinical Practice
Select dressings based on exudate control, comfort, and cost 6. Both Fibracol and Promogran are more expensive than basic moisture-retentive dressings without proven superior outcomes in diabetic foot ulcers. Standard care with sharp debridement and basic dressings that maintain a moist wound environment remains the evidence-based approach 4.